Yew Bio-Pharm Group, Inc. Gross Margin
- Gross margin · 12 months: Value 0.56%; Formula and calculation Gross profit / revenue. Period ending 2021-09-30..
Gross margin
Overview →Financial period ending 2021-09-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Gross margin · 12 months | 0.56% | Gross profit / revenue. Period ending 2021-09-30. $162.90K ÷ $29.05M × 100 ≈ 0.56% |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Gross profit | 162.90K USD | Gross Profit |
| Revenue | 29.05M USD | Revenue from Contract with Customer, Excluding Assessed Tax |
| Cost of products and services | (m) | Cost of Goods and Services Sold |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Gross profit (USD) | Revenue (USD) | Cost of products and services (USD) | Gross margin |
|---|---|---|---|---|
| 2021-09-30 | $162.90K | $29.05M | (m) | 0.56% |
| 2021-06-30 | $2.53M | $39.30M | (m) | 6.43% |
| 2021-03-31 | $4.04M | $34.02M | (m) | 11.88% |
| 2020-12-31 | $3.53M | $27.31M | (m) | 12.92% |
| 2020-09-30 | $2.26M | $25.08M | (m) | 9.02% |
| 2020-06-30 | (m) | $15.40M | (m) | (m) |
| 2020-03-31 | (m) | $18.40M | $10.02M | (m) |
| 2019-12-31 | (m) | $27.88M | $10.00M | (m) |
| 2019-09-30 | (m) | (m) | (m) | (m) |
| 2019-06-30 | $8.70M | $43.82M | $11.00M | 19.84% |
| 2019-03-31 | $11.40M | $46.08M | $1.26M | 24.75% |
| 2018-12-31 | $10.72M | $37.60M | $1.24M | 28.52% |
| 2018-09-30 | $-1.50M | $37.39M | $8.68M | -4.01% |
| 2018-06-30 | $-2.21M | $34.91M | $8.55M | -6.34% |
| 2018-03-31 | $5.02M | $35.70M | $12.52M | 14.07% |
| 2017-12-31 | $5.06M | $40.54M | $17.81M | 12.49% |
| 2017-09-30 | $10.63M | $47.05M | $26.34M | 22.60% |
| 2017-06-30 | (m) | (m) | (m) | (m) |
| 2017-03-31 | $2.36M | $50.60M | $29.36M | 4.67% |
| 2016-12-31 | $3.23M | $51.35M | $24.69M | 6.30% |
| 2016-09-30 | $6.23M | $56.61M | $22.38M | 11.00% |
| 2016-06-30 | $6.23M | $46.94M | $16.63M | 13.26% |
| 2016-03-31 | $6.96M | $35.55M | $11.36M | 19.56% |
| 2015-12-31 | $7.03M | $29.57M | $11.10M | 23.78% |
| 2015-09-30 | $6.27M | $14.20M | $4.38M | 44.18% |
| 2015-06-30 | $6.26M | $10.90M | $2.72M | 57.43% |
| 2015-03-31 | $5.52M | $8.30M | $1.54M | 66.51% |
| 2014-12-31 | $5.59M | $7.73M | $1.58M | 72.35% |
| 2014-09-30 | $5.89M | $7.82M | $1.65M | 75.31% |
| 2014-06-30 | $5.39M | $7.67M | $2.04M | 70.31% |
| 2014-03-31 | $5.35M | $7.71M | $1.89M | 69.43% |
| 2013-12-31 | $5.03M | $7.44M | $1.97M | 67.64% |
| 2013-09-30 | $5.18M | $7.34M | $1.69M | 70.52% |
| 2013-06-30 | $5.42M | $7.17M | $1.22M | 75.50% |
| 2013-03-31 | $5.42M | $6.97M | $1.31M | 77.77% |
| 2012-12-31 | $5.45M | $6.73M | $1.10M | 80.99% |
| 2012-09-30 | $5.40M | $6.38M | $776.88K | 84.73% |
| 2012-06-30 | $5.21M | $6.21M | $850.59K | 83.83% |
| 2012-03-31 | (m) | (m) | (m) | (m) |
| 2011-12-31 | $4.84M | $5.96M | $741.51K | 81.11% |
| 2011-09-30 | (m) | (m) | (m) | (m) |
| 2011-06-30 | (m) | (m) | (m) | (m) |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.